Latest News for OST
Regulatory feedback recent from April 2026 EU EMA and Australian TGA meetings Remaining Q2-2026 regulatory meetings include two U.S. FDA meetings and one UK MHRA meeting, in addition to follow-up meetings with EU EMA and Australian TGA New York, New York--(Newsfile Corp. - April 27, 2026) - OS Therapies, Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in gene-edited, listeria-based…
New York, New York--(Newsfile Corp. - April 17, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Ostin (OST) To Contact Him Directly To Discuss Their Options
NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ostin Technology Group Co., Ltd. (NASDAQ: OST).
New York, New York--(Newsfile Corp. - April 16, 2026) - Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OST.
U.S. House Trading
No House trades found for OST.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.